bf/NASDAQ:SMMT_icon.jpeg

NASDAQ:SMMT

Summit Therapeutics Inc.

  • Stock

USD

Last Close

12.86

30/08 20:00

Market Cap

5.82B

Beta: −1.02

Volume Today

2.05M

Avg: 2.06M

PE Ratio

−1.63

PFCF: −51.96

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jan '14
Jan '15
Jan '16
Jan '17
Jan '18
Jan '19
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.27M
-
2.27M
0%
2.88M
-
35.98M
1,149.35%
56.41M
56.79%
811.37K
98.56%
860K
5.99%
1.81M
110.35%
704.29K
61.07%
cost of revenue
97.67K
-
24.92K
74.49%
199.50K
700.59%
2.51M
-
2.05M
18.46%
gross profit
2.27M
-
2.27M
0%
2.88M
-
35.88M
1,145.95%
56.39M
57.15%
611.87K
98.91%
860K
40.55%
1.81M
110.35%
-1.81M
200.04%
-2.05M
13.28%
selling and marketing expenses
2.65M
-
-2.05M
-
general and administrative expenses
3.24M
-
6.80M
109.86%
7.45M
9.70%
10.35M
38.79%
16.98M
64.16%
16.19M
4.69%
9.29M
42.62%
19.23M
107.05%
23.61M
22.77%
26.70M
13.08%
30.27M
13.35%
selling general and administrative expenses
3.24M
-
6.80M
109.86%
7.45M
9.70%
10.35M
38.79%
16.98M
64.16%
16.19M
4.69%
11.94M
26.25%
19.23M
61.10%
23.61M
22.77%
26.70M
13.08%
28.21M
5.67%
research and development expenses
10.83M
-
15.64M
44.40%
23.94M
53.14%
23.69M
1.06%
41.01M
73.10%
51.38M
25.30%
41.99M
18.28%
53.27M
26.88%
85.35M
60.21%
52.00M
39.08%
59.47M
14.37%
other expenses
-682.90K
-
-682.90K
0%
-3.14M
360.02%
-1.95M
37.94%
-3.86M
97.83%
-19.88M
415.36%
-19.31M
-
-20.97M
8.57%
-14.42M
31.25%
520.91M
3,713.45%
cost and expenses
13.33M
-
19.29M
44.65%
29.45M
52.67%
33.94M
15.27%
54.13M
59.47%
47.69M
11.91%
55.71M
16.82%
53.19M
4.52%
88.00M
65.42%
64.28M
26.95%
89.74M
39.60%
operating expenses
13.33M
-
19.29M
44.65%
29.45M
52.67%
33.94M
15.27%
54.13M
59.47%
47.69M
11.91%
53.92M
13.08%
53.19M
1.36%
88.00M
65.42%
64.28M
26.95%
87.69M
36.41%
interest expense
-14.85K
-
-351.06K
2,264.76%
1.08M
406.91%
1.65M
52.92%
556.10K
66.25%
41.75K
92.49%
255K
510.76%
281K
10.20%
4.40M
1,466.19%
16.46M
274.03%
ebitda
-11.02M
-
-19.38M
75.77%
-30.09M
55.31%
-30.98M
2.96%
-13.42M
56.68%
13.87M
203.36%
-53.11M
482.84%
-51.48M
3.08%
-86.19M
67.43%
-60.80M
29.45%
-87.69M
44.21%
operating income
-11.07M
-
-19.15M
73.06%
-28.73M
50.04%
-31.07M
8.11%
-18.25M
41.25%
12.38M
167.84%
-54.90M
543.42%
-53.19M
3.11%
-86.19M
62.03%
-72.09M
16.36%
-89.74M
24.48%
depreciation and amortization
42.89K
-
49.72K
15.93%
68.36K
37.49%
72.50K
6.05%
4.83M
6,559.78%
1.49M
69.09%
1.79M
19.73%
1.72M
3.86%
2.46M
42.90%
11.29M
359.71%
2.05M
81.84%
total other income expenses net
9K
-
14.85K
64.95%
76.84K
417.61%
42.73K
44.40%
2.83M
6,529.12%
-5.78M
304.17%
18.43M
418.72%
283K
98.46%
-2.42M
953.71%
-6.69M
177.03%
-526.14M
7,761.02%
income before tax
-11.05M
-
-19.07M
72.60%
-28.69M
50.42%
-32.13M
11.99%
-15.42M
52.02%
6.60M
142.80%
-36.47M
652.70%
-52.91M
45.08%
-88.60M
67.46%
-78.78M
11.08%
-615.87M
681.74%
income tax expense
-1.00M
-
-1.95M
95.17%
-4.36M
122.86%
-5.42M
24.44%
-5.32M
1.75%
-3.27M
38.52%
-5.81M
77.41%
-213K
96.33%
-2.46M
1,052.58%
-4.40M
79.27%
-946K
78.50%
net income
-10.05M
-
-17.12M
70.35%
-24.34M
42.15%
-26.71M
9.76%
-10.09M
62.21%
9.87M
197.80%
-30.66M
410.59%
-52.70M
71.86%
-86.15M
63.48%
-74.38M
13.66%
-614.93M
726.73%
weighted average shs out
4.83M
-
39.60M
720.25%
59.10M
49.25%
61.55M
4.14%
65.03M
5.65%
86.14M
32.48%
164.15M
90.55%
69.52M
57.64%
92.24M
32.67%
193.34M
109.60%
619.65M
220.50%
weighted average shs out dil
4.83M
-
39.60M
720.25%
59.10M
49.25%
61.55M
4.14%
65.43M
6.31%
86.14M
31.65%
164.15M
90.55%
69.52M
57.64%
92.24M
32.67%
193.34M
109.60%
619.65M
220.50%
eps
-2.08
-
-0.43
79.33%
-0.41
4.65%
-0.43
4.88%
-0.15
65.12%
0.11
173.33%
-0.19
272.73%
-0.76
300.00%
-0.93
22.37%
-0.38
59.14%
-0.99
160.53%
epsdiluted
-2.08
-
-0.43
79.33%
-0.41
4.65%
-0.43
4.88%
-0.15
65.12%
0.11
173.33%
-0.19
272.73%
-0.76
300.00%
-0.93
22.37%
-0.38
59.14%
-0.99
160.53%

All numbers in USD (except ratios and percentages)